PRDM16 and acute myeloid leukemia: However, while PRDM16 expression in AML has been associated with varied prognoses depending on specific cytogenetic risk groups, PRDM16 expression shows considerable variability within other AML subtypes, particularly in cases with a normal karyotype [18, 23].